Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma
Clinical trial NCT00446095 · COMPLETED
Trial details
- NCT number
- NCT00446095
- Sponsor
- Rigel Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Primary completion
- 2010-04-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.